Russel Berrie Nanotechnology Institute, Technion, 32000, Haifa, Israel.
Faculty of Biomedical Engineering, Technion, 32000, Haifa, Israel.
Sci Rep. 2022 May 3;12(1):7159. doi: 10.1038/s41598-022-11168-x.
Artificial cell fusion often serves as a valuable tool for studying different applications in biology and medicine, including natural development, immune response, cancer metastasis and production of therapeutic molecules. Plasmonic cell fusion, a technique that uses specific cell labeling by gold nanoparticles and resonant femtosecond pulse irradiation for fusing neighboring cells, has been demonstrated useful for such applications, allowing high cell specificity and an overall low toxicity. Despite these advantages, the numerous experimental factors contributing to plasmonic fusion have often led to subpar fusion efficiencies, requiring repeated experiments and extensive calibration protocols for achieving optimal results. In this work we present a study that aims to improve the overall performance of plasmonic cell fusion in terms of fusion efficiency and cell viability. By varying the pulse fluence, nanoparticle concentration, incubation times, and culture handling protocols, we demonstrate up to 100% fusion of malignant epithelial cells across the entire irradiated area of the culture. We also show that some of the smaller cells may stay viable for up to several days. The results would allow plasmonic fusion to play a key role in numerous studies and applications that require specific, high-efficiency cell-cell fusion.
人工细胞融合通常是研究生物学和医学中不同应用的有价值的工具,包括自然发育、免疫反应、癌症转移和治疗分子的生产。等离子体细胞融合是一种使用金纳米粒子对特定细胞进行标记,并通过共振飞秒脉冲辐射融合相邻细胞的技术,已被证明对这些应用有用,具有高细胞特异性和整体低毒性。尽管有这些优势,但导致等离子体融合效率不佳的众多实验因素,往往需要重复实验和广泛的校准协议来获得最佳结果。在这项工作中,我们旨在提高等离子体细胞融合在融合效率和细胞活力方面的整体性能。通过改变脉冲能量、纳米粒子浓度、孵育时间和培养处理方案,我们证明了恶性上皮细胞在整个培养区域的融合效率高达 100%。我们还表明,一些较小的细胞可能在数天内保持存活。这些结果将使等离子体融合在需要特定、高效细胞融合的众多研究和应用中发挥关键作用。